LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 2521 | 3846 | 0.6555 | 0.5843 |
Hs 578T | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3188 | 3846 | 0.8290 | 0.7937 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 658 | 4173 | 3846 | 1.0852 | 1.1027 |
Hs 578T | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 658 | 2954 | 3846 | 0.7681 | 0.7202 |
Hs 578T | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3776 | 3846 | 0.9819 | 0.9782 |
Hs 578T | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 658 | 2259 | 3846 | 0.5874 | 0.5022 |
Hs 578T | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3932 | 3846 | 1.0225 | 1.0271 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 658 | 1169 | 3846 | 0.3040 | 0.1603 |
Hs 578T | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3424 | 3846 | 0.8903 | 0.8677 |
Hs 578T | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3655 | 3846 | 0.9504 | 0.9402 |
Hs 578T | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3417 | 3846 | 0.8884 | 0.8654 |
Hs 578T | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3770 | 3846 | 0.9802 | 0.9761 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3634 | 3846 | 0.9450 | 0.9337 |
Hs 578T | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 658 | 605 | 3846 | 0.1575 | -0.0165 |
Hs 578T | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3276 | 3846 | 0.8519 | 0.8213 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 658 | 3556 | 3846 | 0.9246 | 0.9090 |
Hs 578T | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3759 | 3846 | 0.9774 | 0.9728 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3080 | 3846 | 0.8008 | 0.7597 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 658 | 2361 | 3846 | 0.6140 | 0.5343 |
Hs 578T | PD184352 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3334 | 3846 | 0.8669 | 0.8395 |
Hs 578T | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 658 | 3894 | 3846 | 1.0125 | 1.0150 |
Hs 578T | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 658 | 3621 | 3846 | 0.9416 | 0.9295 |
Hs 578T | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 658 | 3389 | 3846 | 0.8813 | 0.8568 |
Hs 578T | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 3952 | 3846 | 1.0276 | 1.0333 |
Hs 578T | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 658 | 2043 | 3846 | 0.5312 | 0.4344 |